KP Tissue (TSE:KPT – Free Report) had its price objective cut by TD from C$14.00 to C$13.00 in a report issued on Wednesday,BayStreet reports. They currently have a hold rating on the stock.
KP Tissue Stock Up 2.1%
TSE KPT opened at C$12.05 on Wednesday. The company has a 50-day simple moving average of C$12.51 and a two-hundred day simple moving average of C$12.34. KP Tissue has a 12-month low of C$9.21 and a 12-month high of C$13.78. The firm has a market cap of C$120.89 million, a price-to-earnings ratio of 13.69, a PEG ratio of -0.88 and a beta of 0.54.
KP Tissue (TSE:KPT – Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported C$0.24 EPS for the quarter. Equities analysts expect that KP Tissue will post 0.44 earnings per share for the current fiscal year.
KP Tissue Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Thursday, October 15th were given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 7.0%. The ex-dividend date was Tuesday, September 29th. KP Tissue’s dividend payout ratio (DPR) is presently 85.23%.
KP Tissue Company Profile
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Further Reading
- Five stocks we like better than KP Tissue
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
